Post by Cirrus Therapeutics

Cirrus Therapeutics is excited to spotlight Yogeshwar S., PhD, Principal Scientist. An accomplished gene therapy and regenerative medicine scientist with more than a decade of academic and industry experience, Yogeshwar brings deep expertise in AAV-based therapeutics, cell engineering, translational research, and cross-functional drug discovery. His background spans early- and late-stage R&D, advancing programs from concept through IND-enabling work and contributing to patents, publications, and platform development across multiple therapeutic areas. Yogeshwar has built a strong track record in gene therapy research and program leadership, including work at Homology Medicines and Frontera Therapeutics, where he helped develop and advance AAV-based platforms, nominee candidates, and preclinical strategies. His contribution will strengthen Cirrus’ ability to move our differentiated ocular immunology forward with discipline and speed while preserving vision and quality of life for patients. “My interest in vision science was sparked by the eye’s remarkable immune privilege and the possibility of protecting such a complex and vital organ from damaging inflammation,” said Yogeshwar. “What excites me about Cirrus is the chance to help turn cutting-edge science into a one-time therapy that could meaningfully change life for patients facing dry AMD.” Yogeshwar joins Cirrus at an important point in the company’s growth, and his scientific depth, translational mindset, and commitment to patient impact make him an outstanding addition to the team. #vision #AMD #DryAMD #WetAMD #optometry #opthalmology #healthcare #science #STEM #biotech #biopharma #research #lifesciences